JPRN-UMIN000015562已完成未知
Measuring Plasma Orexin Concentrations in Narcolepsy and Idiopathic Hypersomnia - Measuring Plasma Orexin Concentrations
Department of Laboratory Medicine, School of Medicine, Keio University0 个研究点目标入组 100 人开始时间: 2014年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The control group consists of normal subjects without sleep disorders, mental disorders, the direct physiological effects of a substance (e.g., a sedative, hypnotic, or stimulant, etc.), and severe physical diseases. Patients with anemia or renal failure are excluded from the narcolepsy group, the idiopathic hypersomnia group, and the control group.
研究者
相似试验
已完成
不适用
Plasma orexin levels at the emergence of anesthesia and the incidence of post-anesthetic shiveringPatients undergoing general anesthesia with arterial lineJPRN-UMIN000020966Kagoshima University Hospital100
进行中（未招募）
1 期
Oksikodonin analgeettinen pitoisuus plasmassa avo-ja laparoskooppisesti sappileikatuilla aikuispotilaillaPerusterveitä aikuisia, jotka sappileikattujaEUCTR2005-004596-38-FIEskelinen Matti/KYS
招募中
不适用
Evaluation of the effectiveness of the orexin receptor antagonist (Suvorexant) for type 2 diabetes with untreated sleep disorder.type 2 diabetesJPRN-UMIN000023827Toho University School of Medicine40
已完成
不适用
Evaluation of the effectiveness of the orexin receptor antagonist for type 2 diabetes with sleep disorder upon glycemic control.type 2 diabetesJPRN-UMIN000026920Toda Chuo General Hospital20
尚未招募
4 期
Study of effects of Naltrexone treatment in alcohol dependent patients and influence by genotypes.Naltrexone is an FDA approved medication for treating alcohol dependenceCTRI/2017/12/010848avina Suresh